.png){kind=icon}
Return
Disease biomarker identification based on sample network optimization
.png){kind=icon}
PRE
AI
DOI：10.1016/j.ymeth.2023.03.005.png)
.png){kind=icon}
Original request for help.png){kind=icon}
Share.png){kind=icon}
Save
Abstract
En 中文
A large amount of evidence shows that biomarkers are discriminant features related to disease development. Thus, the identification of disease biomarkers has become a basic problem in the analysis of complex diseases in the medical fields, such as disease stage judgment, disease diagnosis and treatment. Research based on networks have become one of the most popular methods. Several algorithms based on networks have been proposed to identify biomarkers, however the networks of genes or molecules ignored the similarities and associations among the samples. It is essential to further understand how to construct and optimize the networks to make the identified biomarkers more accurate. On this basis, more effective strategies can be developed to improve the performance of biomarkers identification. In this study, a multi-objective evolution algorithm based on sample similarity networks has been proposed for disease biomarker identification. Specifically, we design the sample similarity networks to extract the structural characteristic information among samples, which used to calculate the influence of the sample to each class. Besides, based on the networks and the group of biomarkers we choose in every iteration, we can divide samples into different classes by the importance for each class. Then, in the process of evolution algorithm population iteration, we develop the elite guidance strategy and fusion selection strategy to select the biomarkers which make the sample classification more accurate. The experiment results on the five gene expression datasets suggests that the algorithm we proposed is superior over some state-of-the-art disease biomarker identification methods.
Keywords:
Disease biomarker identification
Sample similarity network
Multi-objective evolution algorithm
Sample classification
Journal
IF:
4.3
Papers:
4.9K
Citations:
2.4W
Organization
Cited Papers
Targeted Exome Sequencing of Krebs Cycle Genes Reveals Candidate Cancer-Predisposing Mutations in Pheochromocytomas and Paragangliomas.png)
CLINICAL CANCER RESEARCH
OAAI
CLINICAL CANCER RESEARCHIF10.2
OAAIShareSaveReentrant transition enthalpies of liquid crystals: The frustrated spin-gas model and experiments
PREAI
ShareSaveA statistical framework for assessing pharmacological responses and biomarkers using uncertainty estimatesELIFE
OAAI
ELIFEIF0
OAAIShareSaveShareSaveShareSaveShareSaveShareSave
View more